EP4333840
JAK1 BOÐLEIÐARHEMLAR TIL MEÐFERÐAR VIÐ PRURIGO NODULARIS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.5.2022EP published:
5.11.2025EP application number:
22725046.1
EP translation filed:
28.11.2025Grant published:
15.12.2025EPO information:
European Patent Register
Max expiry date:
2.5.2042Expiry date:
2.5.2026
Title in English:
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF PRURIGO NODULARISLanguage of the patent:
English
Timeline
Today
3.5.2022EP application
5.11.2025EP Publication
28.11.2025Translation submitted
15.12.2025Registration published
2.5.2026Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, DE 19803, US
Inventor
Name:
SMITH, PaulAddress:
Carlsbad, CA 92009, US
Name:
BROWN, Kurt AndrewAddress:
Narberth, PA 19072, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
202163183249 PDate:
3.5.2021Country:
US
Classification
Categories:
A61K 31/4155, A61K 31/519, A61K 31/5377, A61K 39/395, A61K 45/06, A61P 17/00, A61P 17/04, C07K 16/24